Severe botulism after focal injection of botulinum toxin

Neurology

Volumn 67, Issue 10, 2006, Pages 1855-1856

  Souayah, N ^a,b   Karim, H ^a   Kamin, S S ^a   McArdle, J ^a   Marcus, S ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b DOC 8100 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; BOTULISM; CASE REPORT; CONVALESCENCE; DENERVATION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; ELECTROPHYSIOLOGY; FEMALE; HUMAN; LD 50; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; BOTULINUM ANTITOXIN; BOTULINUM TOXIN TYPE A; BOTULISM; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROMYOGRAPHY; FEMALE; HUMANS; INTERNET; MALPRACTICE; MUSCLE WEAKNESS; MUSCLE, SKELETAL; NEUROMUSCULAR AGENTS; NEUROMUSCULAR JUNCTION; OVERDOSE; PARALYSIS; QUADRIPLEGIA; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; SELF MEDICATION; SKIN AGING;

EID: 33845443611     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000244417.34846.b6     Document Type: Article

References (10)

1. Bakheit AM, Ward CD, McLellan DL. Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases. J Neurol Neurosurg Psychiatry 1997;62:198.
2. Bhatia KP, Munchau A, Thompson PD, et al. Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases. J Neurol Neurosurg Psychiatry 1999;67:90-93.
3. Pellizzari R, Rossetto O, Schiavo G, Montecucco C. Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses. Philos Trans R Soc Lond B Biol Sci 1999;354:259-268.
4. Schiavo G, Rossetto O, Tonello F, Montecucco C. Intracellular targets and metalloprotease activity of tetanus and botulism neurotoxins. Curr Top Microbiol Immunol 1995;195:257-274.
5. Dumitru D, Amato AA, Zwarts MJ. Electrodiagnostic medicine, 2nd ed. Philadelphia: Hanley & Belfus, 2002.
6. Pickett JB3rd . AAEE case report #16: botulism. Muscle Nerve 1988;11:1201-1205.
7. Tacket CO, Shandera WX, Mann JM, Hargrett NT, Blake PA. Equine antitoxin use and other factors that predict outcome in type A foodborne botulism. Am J Med 1984;76:794-798.
8. Dolly JO, Black J, Williams RS, Melling J. Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization. Nature 1984;307:457-460.
9. Hambleton P. Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use. J Neurol 1992;239:16-20.
10. Holland RL, Brown MC. Nerve growth in botulinum toxin poisoned muscles. Neuroscience 1981;6:1167-1179.